As of Friday, I-Mab’s (NASDAQ:IMAB) stock closed at $6.76, up from $6.72 the previous day. While I-Mab has overperformed by 0.60%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, IMAB fell by -79.36%, with highs and lows ranging from $34.85 to $3.19, whereas the simple moving average fell by -11.09% in the last 200 days.
On December 09, 2021, Siebert Williams Shank started tracking I-Mab (NASDAQ: IMAB) recommending Buy. A report published by Daiwa Securities on June 02, 2021, Initiated its previous ‘Buy’ rating for IMAB. Needham also rated IMAB shares as ‘Buy’, setting a target price of $75 on the company’s shares in an initiating report dated March 15, 2021. H.C. Wainwright Reiterated the rating as Buy on March 03, 2021, but set its price target from $55 to $75. Piper Sandler initiated its ‘Overweight’ rating for IMAB, as published in its report on February 25, 2021. H.C. Wainwright’s report from December 07, 2020 suggests a price prediction of $55 for IMAB shares, giving the stock a ‘Buy’ rating. Cantor Fitzgerald also rated the stock as ‘Overweight’.
Analysis of I-Mab (IMAB)
Further, the quarter-over-quarter increase in sales is 191.70%, showing a positive trend in the upcoming months.
One of the most important indicators of I-Mab’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -46.80% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.30, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and IMAB is recording 553.41K average volume. On a monthly basis, the volatility of the stock is set at 14.79%, whereas on a weekly basis, it is put at 13.73%, with a gain of 5.79% over the past seven days. Furthermore, long-term investors anticipate a median target price of $37.36, showing growth from the present price of $6.76, which can serve as yet another indication of whether IMAB is worth investing in or should be passed over.
How Do You Analyze I-Mab Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.61%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 50.80% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in IMAB shares?
The recent increase in stakes in IMAB appears to be a result of several institutional investors and hedge funds increasing their positions. During the last quarter, the company picked up 0 additional shares for a total stake of worth $19.69 million, bringing number of shares owned by the company to 4,709,783.
At the end of the first quarter, BlackRock Fund Advisors increased its IMAB holdings by 34.88% and now holds 2.08 million IMAB shares valued at $8.69 million with the added 0.54 million shares during the period. IMAB shares are owned by institutional investors to the tune of 50.80% at present.